semaglutide step 4 2.4-mg Injection as a Novel Approach for Chronic Weight Management Two-year effects of semaglutide in

Originally approved by the FDA to manage type 2 diabetes, semaglutide gained widespread attention when clinical trials showed extraordinary results for weight loss leading to FDA approval specifically for chronic weight management under the brand name Wegovy

four Member Commitments required

1).29,32 With respect to the vascular system, rGLP-1 activation induces modest decreases in blood pressure,33,34 it has a vasodilator effect, improves arterial stiffness, and prevents atherosclerotic plaque formation-and has plaque stabilizing effects-through its anti-inflammatory and antiapoptotic effects as demonstrated in animal models.29,32,3538 Despite controversies about rGLP-1 expression in vascular smooth muscle and endothelial cells, studies have shown that arGLP-1 has antiproliferative effects on these cells,39 reduces oxidative stress, improves endothelial function, and increases nitric oxide production in experimental models.3540 In the heart they produce a discrete increase in heart rate (24 beats/min), although this does not seem to be associated with an increase in arrhythmias or cardiovascular events

Hypoglycemia: Only a concern if you're also on insulin or sulfonylureas